Suresh Narva

804 total citations
37 papers, 621 citations indexed

About

Suresh Narva is a scholar working on Organic Chemistry, Molecular Biology and Surgery. According to data from OpenAlex, Suresh Narva has authored 37 papers receiving a total of 621 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 13 papers in Molecular Biology and 11 papers in Surgery. Recurrent topics in Suresh Narva's work include Synthesis and Biological Evaluation (7 papers), Synthesis and biological activity (6 papers) and Cancer therapeutics and mechanisms (6 papers). Suresh Narva is often cited by papers focused on Synthesis and Biological Evaluation (7 papers), Synthesis and biological activity (6 papers) and Cancer therapeutics and mechanisms (6 papers). Suresh Narva collaborates with scholars based in India, China and Japan. Suresh Narva's co-authors include Kondapalli Venkata Gowri Chandra Sekhar, Wen Zhang, Ramaswamy Ganesh, Malathi Sathiyasekaran, Kang Zhou, Mallika Alvala, Nishant Jain, Yanling Wu, Subash Babu and Nathella Pavan Kumar and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Frontiers in Immunology.

In The Last Decade

Suresh Narva

35 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suresh Narva India 15 269 192 103 103 88 37 621
Zhijian Zhu China 12 169 0.6× 172 0.9× 31 0.3× 33 0.3× 86 1.0× 37 491
Menghua Wang China 15 175 0.7× 351 1.8× 25 0.2× 79 0.8× 31 0.4× 32 643
Chengda Zhang China 14 102 0.4× 125 0.7× 75 0.7× 94 0.9× 81 0.9× 49 553
Hitesh Batra United States 15 264 1.0× 104 0.5× 71 0.7× 66 0.6× 50 0.6× 29 635
Yanbin Pan China 15 200 0.7× 362 1.9× 32 0.3× 48 0.5× 89 1.0× 30 676
Yanjie Wang China 12 54 0.2× 102 0.5× 63 0.6× 30 0.3× 83 0.9× 40 395
Yucheng Wang China 13 66 0.2× 106 0.6× 31 0.3× 78 0.8× 67 0.8× 29 353
Chiara Ciaprini Italy 11 203 0.8× 70 0.4× 27 0.3× 80 0.8× 128 1.5× 18 747
Gina Eagle United States 13 46 0.2× 110 0.6× 95 0.9× 189 1.8× 243 2.8× 39 598
Junichi Seki Japan 12 113 0.4× 126 0.7× 59 0.6× 65 0.6× 31 0.4× 36 370

Countries citing papers authored by Suresh Narva

Since Specialization
Citations

This map shows the geographic impact of Suresh Narva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suresh Narva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suresh Narva more than expected).

Fields of papers citing papers by Suresh Narva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suresh Narva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suresh Narva. The network helps show where Suresh Narva may publish in the future.

Co-authorship network of co-authors of Suresh Narva

This figure shows the co-authorship network connecting the top 25 collaborators of Suresh Narva. A scholar is included among the top collaborators of Suresh Narva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suresh Narva. Suresh Narva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiao, Mi Zhang, Panpan Wang, et al.. (2022). Design, synthesis and bioactivity of novel naphthalimide-benzotriazole conjugates against A549 cells via targeting BCL2 G-quadruplex and inducing autophagy. Life Sciences. 302. 120651–120651. 10 indexed citations
2.
Narva, Suresh, Mi Zhang, Ce Li, et al.. (2021). Synthesis of imidazo[1,2-f]phenanthridine derivatives under a metal- and base-free condition and their anticancer activity. Tetrahedron Letters. 68. 152908–152908. 6 indexed citations
3.
Wang, Ming, Xudong Ma, Kang Zhou, et al.. (2021). Discovery of Pyrrole-imidazole Polyamides as PD-L1 Expression Inhibitors and Their Anticancer Activity via Immune and Nonimmune Pathways. Journal of Medicinal Chemistry. 64(9). 6021–6036. 11 indexed citations
4.
Kumar, Nathella Pavan, Syed Hissar, Kannan Thiruvengadam, et al.. (2021). Discovery and Validation of a Three-Cytokine Plasma Signature as a Biomarker for Diagnosis of Pediatric Tuberculosis. Frontiers in Immunology. 12. 653898–653898. 18 indexed citations
5.
Narva, Suresh, et al.. (2020). Synthesis and Evaluation of Biphenyl-1,2,3-Triazol-Benzonitrile Derivatives as PD-1/PD-L1 Inhibitors. ACS Omega. 5(33). 21181–21190. 10 indexed citations
6.
Chen, An, Dongliang Wu, Jia Shi, et al.. (2020). Design, synthesis and biological evaluation of 2-methyl-(1,1′-biphenyl)-pyrimidine conjugates. Bioorganic & Medicinal Chemistry Letters. 30(16). 127328–127328. 8 indexed citations
7.
Awadasseid, Annoor, Suresh Narva, Song Cao, et al.. (2020). Anti-cancer activity of benzoxazinone derivatives via targeting c-Myc G-quadruplex structure. Life Sciences. 258. 118252–118252. 20 indexed citations
9.
Narva, Suresh, et al.. (2018). Design, Synthesis, and Biological Evaluation of 2‐(4‐Aminophenyl)benzothiazole Analogues as Antiproliferative Agents. Journal of Heterocyclic Chemistry. 56(2). 520–532. 16 indexed citations
10.
Ganesh, Ramaswamy, et al.. (2017). A 6-year-old boy with Wilson disease—A diagnostic dilemma. Indian Journal of Gastroenterology. 36(2). 149–154. 1 indexed citations
11.
Narva, Suresh, et al.. (2016). Design, Synthesis and Biological Evaluation of New Substituted Sulfonamide Tetrazole Derivatives as Antitubercular Agents. ChemistrySelect. 1(8). 1705–1710. 12 indexed citations
12.
Narva, Suresh, et al.. (2016). Synthesis and biological evaluation of pyrrolo[2,3- b ]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA. European Journal of Medicinal Chemistry. 114. 220–231. 42 indexed citations
13.
Narva, Suresh, et al.. (2014). Synthesis and evaluation of anti-tubercular activity of 6-(4-substitutedpiperazin-1-yl) phenanthridine analogues. European Journal of Medicinal Chemistry. 74. 333–339. 30 indexed citations
14.
Narva, Suresh, Janupally Renuka, Vikrant Singh Rajput, et al.. (2013). Synthesis and evaluation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl)acetyl)piperazin-1-yl)quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents. European Journal of Medicinal Chemistry. 71. 324–332. 38 indexed citations
15.
Narva, Suresh, et al.. (2013). Synthesis of novel ciprofloxacin analogues and evaluation of their anti-proliferative effect on human cancer cell lines. Bioorganic & Medicinal Chemistry Letters. 23(23). 6292–6295. 43 indexed citations
16.
Narva, Suresh & Jhuma Sankar. (2010). Macrophage activation syndrome: a rare complication of incomplete Kawasaki disease. Annals of Tropical Paediatrics. 30(1). 61–64. 10 indexed citations
17.
Narva, Suresh, et al.. (2008). Evaluation of chronic abdominal pain - A test of “patience”. The Indian Journal of Pediatrics. 75(12). 1259–1260.
18.
Balasubramanian, Sundaram, et al.. (2008). Comparison of oxygen saturation levels by pulse oximetry in healthy children aged 1 month to 5 years residing at an altitude of 1500 metres and at sea level. Annals of Tropical Paediatrics. 28(4). 267–273. 4 indexed citations
19.
Narva, Suresh, et al.. (2007). Kawasaki disease in south India: a prospective, case–control study. Annals of Tropical Paediatrics. 27(4). 277–283. 9 indexed citations
20.
Ganesh, Ramaswamy, et al.. (2006). Crohn’s disease presenting as palatal ulcer. The Indian Journal of Pediatrics. 73(3). 229–231. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026